B-SAFE Trial

Biomarker and Stroke Prevention in Atrial Fibrillation using Electronic Decision Support

We are now inviting general practices to participate in B-SAFE or the ‘Biomarkers for Stroke Prevention in Atrial Fibrillation using Electronic decision support (EDS)’ study. The study, which is funded by the Health Research Council of NZ and approved by HDEC, will compare an Electronic Decision Support (EDS) tool with usual care. It will also evaluate the utility of cardiac biomarkers (BNP and troponin) in guiding management of atrial fibrillation.

The study is designed to minimize impact on busy GP practices. The EDS tool is concise and takes just a few minutes to complete. The tool will provide an individualized check list for anticoagulation, steps to reduce bleeding risk, and advice on heart rate control and overall cardiovascular risk management.

In this short video Professor Ralph Stewart (Cardiologist, Auckland City Hospital) will explain more about the B-SAFE trial and introduce you to the Atrial Fibrillation EDS tool.

If you want further information about this study or if your practice would like to take part in this study please enter your details in the form below: